In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Macrogenics Inc (NASDAQ: MGNX) closed at $16.05 in the last session, down -1.95% from day before closing price of $16.37. In other words, the price has decreased by -$1.95 from its previous closing price. On the day, 0.73 million shares were traded. MGNX stock price reached its highest trading level at $16.37 during the session, while it also had its lowest trading level at $15.62.
Ratios:
We take a closer look at MGNX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on April 26, 2024, initiated with a Buy rating and assigned the stock a target price of $25.
BTIG Research reiterated its Buy rating for the stock on March 04, 2024, while the target price for the stock was revised from $12 to $24.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 04 ’24 when Peters Jeffrey Stuart sold 51,395 shares for $15.55 per share. The transaction valued at 799,148 led to the insider holds 0 shares of the business.
Peters Jeffrey Stuart sold 19,625 shares of MGNX for $421,938 on Mar 06 ’24. The Senior VP and General Counsel now owns 8,895 shares after completing the transaction at $21.50 per share. On Mar 04 ’24, another insider, Risser Eric Blasius, who serves as the Chief Operating Officer of the company, sold 41,159 shares for $19.76 each. As a result, the insider received 813,501 and left with 38,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGNX now has a Market Capitalization of 1004096000 and an Enterprise Value of 806199808. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.09 while its Price-to-Book (P/B) ratio in mrq is 6.53. Its current Enterprise Value per Revenue stands at 13.723 whereas that against EBITDA is -5.083.
Stock Price History:
Over the past 52 weeks, MGNX has reached a high of $21.88, while it has fallen to a 52-week low of $4.29. The 50-Day Moving Average of the stock is -2.69%, while the 200-Day Moving Average is calculated to be 58.66%.
Shares Statistics:
According to the various share statistics, MGNX traded on average about 1.46M shares per day over the past 3-months and 705730 shares per day over the past 10 days. A total of 62.07M shares are outstanding, with a floating share count of 58.52M. Insiders hold about 6.45% of the company’s shares, while institutions hold 95.00% stake in the company. Shares short for MGNX as of 1713139200 were 8599115 with a Short Ratio of 5.90, compared to 1710460800 on 5602561. Therefore, it implies a Short% of Shares Outstanding of 8599115 and a Short% of Float of 16.88.
